Skip to content

Author

Zhen-Qiang Zhang

We have 4 of 146 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Nov 2026

Astrocytic metabolic reprogramming in Parkinson’s disease: mechanistic crosstalk and therapeutic opportunities

Abstract Parkinson’s disease (PD), a neurodegenerative disorder, is predominantly characterized by the depletion of dopaminergic neurons in the substantia nigra pars compacta and the aberrant aggregation of α-synuclein (α-syn). Recent research has indicated that astrocytes not only function as indispensable supportive...

Ya-Li Zhan, Yong Zhang, Zhen-Qiang Zhang et al. · 0 citations
#gene editing Review Open access Nov 2026

Gene therapy for epilepsy: From SCN1A to broadened therapeutic horizons (Review).

Five nucleic acid‑based therapeutic strategies are examined, namely gene supplementation, enhancement of endogenous gene expression, gene silencing, DNA editing and RNA editing, for major causative genes, using mutation‑specific functional consequences [loss‑of‑function (LOF) vs. gain‑of‑function] as the primary framew...

Ruo-Tong Qin, Xiao-Ge Hu, Wei Jiang et al. · 0 citations
Oct 2026

Sesquiterpenes from the rhizomes of Acorus calamus var. angustatus Besser and their neuroprotective properties.

Five sesquiterpenes were isolated from the dried rhizomes of Acorus calamus var. angustatus Besser. Their structures were determined by spectroscopic analysis and ECD calculations, including one new eudesmane-type sesquiterpene, 2-hydroxy-eudesmane K (1), and four known compounds: eudesmane K (2), isocalamendiol (3), a...

Yuan-Fang Zhang, Yi-Nan Zhao, Yao Ren et al. · 0 citations
Aug 2026

Deep learning-driven discovery and optimization of natural LSD1 inhibitors for the treatment of Alzheimer's disease.

This study provides a generalized DTA tool for early-stage drug development, and identifies S3 as a novel LSD1 inhibitor with potent anti-AD efficacy, by addressing unmet demands for AI-assisted anti-AD lead discovery.

Zhong-Hua Li, Tiancheng Sun, M. Han et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.